Medical Doctor Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

John Bursell

Physical Medicine & Rehabilitation Juneau, AK Medical Doctor

NPI 1295829745 CMS profile 997206

3220 Hospital Dr, Suite 101, Juneau, AK 99801

Open in the dashboard

General payments

$426

4 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, John Bursell of Juneau, AK is reported in the CMS Open Payments database as having received $426 across 4 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 58th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $259 3
2024 General $167 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Bursell
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to John Bursell were reported at $259. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year John Bursell Physical Medicine & Rehabilitation median Middle half National median
2019 $0 $133 $45–$390 $163
2020 $0 $88 $29–$272 $114
2021 $0 $116 $33–$360 $132
2022 $0 $123 $40–$378 $149
2023 $0 $131 $43–$396 $160
2024 $167 $141 $45–$409 $164
2025 $259 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Stryker Corporation $426 4 payments

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Food and Beverage $426 4 payments
Products named General payments · program years 2024–2025
  1. MAKO Joint Replacement Hips, Knees $171 1 payment
  2. MAKO Knees, Hips $167 1 payment
  3. VARIAX $88 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 4 drugs

Part D claims

88

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$399

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

39.8%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 21 $181
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 35 $142
Methylprednisolone Generic 17 $70
Alprazolam Generic 15 $6

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 89 billing codes

Paid by Medicare

$325,837

Of which drugs: $1,854

Medicare patients

575

Average age 73

Services billed

14,816

333 women, 242 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 60%
Arthritis 56%
Diabetes 19%
Atrial fibrillation 13%
Cancer 13%
Depression 13%
Ischemic heart disease 12%
Osteoporosis 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 102 5,969 $603
Injection, methylprednisolone acetate, 40 mg J1030 Office 38 54 $238

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

4 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record